Thailand Reverses Marijuana Legalization Amidst New Government

Regulations by 2FIRSTS.ai

Jan.11.2024

Thailand Reverses Marijuana Legalization Amidst New Government

Thailand's newly elected prime minister announces plans to re-ban recreational marijuana use within six months of taking office.

According to a report by hsbnoticias, Thailand's historic decision to legalize recreational marijuana seems to be in jeopardy as the country prepares for a government change in September 2023. The newly elected Prime Minister, Srettha Thavisin, has made a pact with the elite class and has promised to re-ban the recreational use of marijuana within the first six months of his term.

On January 9, 2024, the Ministry of Health in Thailand issued a legislation proposing fines or even imprisonment for violators. However, the consumption of cannabis in public places remains prohibited, and a complete industry has emerged around the recreational use of cannabis, including advertising and marketing.

Former Thai Minister of Health Anutin Charnvirakul stated that the intention behind the legalization of cannabis was not to encourage Thai people to consume it.

Thailand to Implement Medical Cannabis Policy. We never intended to endorse the recreational use of cannabis or promote its use in a manner that may cause discomfort to others," he stated.

References:

[1] Tailandia busca prohibir de nuevo el consumo recreativo de marihuana

Also Read:

[1] Reassessing E-cigarette and New Tobacco Legislation in Thailand

[2] WHO: Strengthening E-Cig Enforcement and Monitoring in Thailand to Prevent Addiction Tragedies

[3] Thai Medical Student Association Calls for Smoke-Free Parliament

#Traditional tobacco #Legislation #Asia #Thailand #Marijuana #Medical marijuana dispensary

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most

In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.

Oct.21

2Firsts Monitor | FOGER website flags customs & tariff delays; some products out of stock

2Firsts observed on FOGER’s online retail site “FOGER VAPES” that the platform indicates restocking delays due to customs and tariff factors. Several items show limited availability or “sold out” status, with a restock alert feature offered. A previous article on the site also referenced potential tariff changes that may affect pricing.

Nov.05

BAT Subsidiary Warns of Surge in Illegal Nicotine Pouches in Canada, Calls for Unified Regulatory Framework

Imperial Tobacco Canada, a subsidiary of British American Tobacco, has urged the federal government to respond to the spread of illegal nicotine pouches by allowing approved products to be sold through a wider range of adult retail channels. The company is also calling for stronger retail inspections, enhanced digital tracking, and closer coordination among provinces to build a consistent regulatory framework and restore the accessibility of the legal market.

Dec.05 by 2FIRSTS.ai

UK Retailers Urge Government to Include Age-Verification Tech in Tobacco and Vapes Bill

UK convenience retailers have written to several government ministers urging the adoption of age-verification technology in the Tobacco and Vapes Bill. The letter, led by Atul Sodha of Londis, Harefield, and co-signed by 29 other shop owners, calls for a “triple lock” approach combining manufacturer tech, retailer vigilance, and user-level verification to curb youth access.